Article

Fading SARS-CoV-2 humoral VOC cross-reactivity versus sustained cellular immunity in…

Research square · 2023 · Krystallenia Paniskaki, author Sarah Goretzki, author Margarethe J. Konik, author Klara Lechtenberg, author Melanie Vogl, author Toni L. Meister, author Stephanie Pfaender, author Markus Zettler, author Jasmin Jäger, author Sebastian Dolff, author Hana Rohn, author Ursula Felderhoff-Mueser, author Oliver Witzke, author Christian Dohna-schwake, author

Key facts

Title Fading SARS-CoV-2 humoral VOC cross-reactivity versus sustained cellular immunity in convalescent children and adolescents
First author Krystallenia Paniskaki, author Sarah Goretzki, author Margarethe J. Konik, author Klara Lechtenberg, author Melanie Vogl, author Toni L. Meister, author Stephanie Pfaender, author Markus Zettler, author Jasmin Jäger, author Sebastian Dolff, author Hana Rohn, author Ursula Felderhoff-Mueser, author Oliver Witzke, author Christian Dohna-schwake, author
Journal Research square
Published Jul 13, 2023
DOI 10.21203/rs.3.rs-3071406/v1
Devices mentioned K073490
Product codes mentioned CFN, KIP, KIT, MVU

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature